Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 401–500 of 1,012
Arsenic–glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs)
Leslie, E. M. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.11.009 · Cited by 166
Current advances on ABC drug transporters in fish
Luckenbach, T., Fischer, S., & Sturm, A. (2014) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2014.05.002 · Cited by 168
Nooter, K., Brutel de la Riviere, G., Look, M., van Wingerden, K., Henzen-Logmans, S., Scheper, R., Flens, M., Klijn, J., Stoter, G., & Foekens, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.414 · Cited by 153
Function of prokaryotic and eukaryotic ABC proteins in lipid transport
Pohl, A., Devaux, P. F., & Herrmann, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.12.007 · Cited by 170
“Furthermore, no significant sitosterol transport by ABCB1 (MDR1 Pgp), ABCC1 (MRP1), and ABCG2 (BCRP) was found [158].”
BackgroundMechanism of multidrug recognition by MDR1/ABCB1
Yasuhisa, K., Shin‐ya, M., Michinori, M., & Kazumitsu, U. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00538.x · Cited by 152
Egner, R., Rosenthal, F. E., Kralli, A., Sanglard, D., & Kuchler, K. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.2.523 · Cited by 152
“Hence, development of PDR in yeast is similar to an important type of MDR in mammalian cells (Kane, 1996) mediated by the overexpression of the MDR1 (Chen et al., 1986) [P-glycoprotein (Pgp)] or multidrug resistance-associated protein (Cole et al., 1992) gene products.”
BackgroundDysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152
Tsujii, H., König, J., Rost, D., Stöckel, B., Leuschner, U., & KEPPLER, D. O. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70459-2 · Cited by 152
zu Schwabedissen, H. E. M., Jedlitschky, G., Gratz, M., Haenisch, S., Linnemann, K., Fusch, C., Cascorbi, I., & Kroemer, H. K. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003335 · Cited by 170
“There are different studies reporting an influence of xenobiotics on the expression level, including cycloheximidine, 2-acetylaminofluorene, and rifampin (Cole et al., 1992; Buchler et al., 1996; Kartenbeck et al., 1996; Fromm et al., 2000).”
BackgroundNovel Mode of Action of Tylophorine Analogs as Antitumor Compounds
Gao, W., Lam, W., Zhong, S., Kaczmarek, C. G., Baker, D. C., & Cheng, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1904 · Cited by 153
“Among the best characterized mechanisms of drug resistance is the overexpression of the multidrug resistance gene (mdr) product, 170-kDa P-glycoprotein (12, 13), or the 190-kDa multidrug resistance protein, MRP (14).”
BackgroundJansen, G., Scheper, R. J., & Dijkmans, B. A. C. (2003) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740310004333 · Cited by 243
MRP1 and its role in anticancer drug resistance
Lu, J. F., Pokharel, D., & Bebawy, M. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1105253 · Cited by 160
“Rather, the resistance was found to be strongly correlated with another protein from the same superfamily, known as MRP1 (Cole et al., 1992).”
BackgroundHayes, J. D., & Pulford, D. J. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083492 · Cited by 469
Linsdell, P., & Hanrahan, J. W. (1998) · The Journal of General Physiology · doi:10.1085/jgp.111.4.601 · Cited by 152
“The ability to pass large cytoplasmic organic anions is also reminiscent of the closely related ABC proteins multidrug resistance protein (MRP; Cole et al., 1992) and canalicular multispecific organic anion transporter (cMOAT; also known as MRP2; Paulusma et al., 1996), both of which mediate the…”
BackgroundSelection for Drug Resistance Results in Resistance to Fas-Mediated Apoptosis
Landowski, T. H., Gleason-Guzman, M. C., & Dalton, W. S. (1997) · Blood · doi:10.1182/blood.v89.6.1854 · Cited by 161
The multidrug transporter ABCG2 (BCRP) is inhibited by plant‐derived cannabinoids
Holland, M. L., Lau, D. T. T., Allen, J. D., & Arnold, J. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707467 · Cited by 150
“Other multidrug transporters believed to contribute to clinical resistance have since been discovered, including the multidrug resistance-related protein 1 (ABCC1/MRP1) (Cole et al., 1992) and more recently, breast cancer resistance protein (ABCG2/BCRP) (Doyle et al., 1998).”
BackgroundGottesman, M. M., & Pastan, I. H. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv222 · Cited by 148
Anticancer drug resistance in primary human brain tumors
Bredel, M. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00045-5 · Cited by 168
Creighton, T. (1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.8.731 · Cited by 162
Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., & Kruh, G. D. (1998) · PubMed · Cited by 149
Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3
Florea, B. I., Cassará, M. L., Junginger, H. E., & Borchard, G. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00356-5 · Cited by 149
Boumendjel, A., Baubichon-Cortay, H., Trompier, D., Perrotton, T., & Pietro, A. D. (2005) · Medicinal Research Reviews · doi:10.1002/med.20032 · Cited by 175
Guo, L., Liu, Y., Bai, Y., Sun, Y., Xiao, F.-M., & Guo, Y. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.043 · Cited by 158
Recent developments in the field of antitumour anthracyclines
Monneret, C. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01244-2 · Cited by 148
Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein
Castro, A. F., & Altenberg, G. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00657-0 · Cited by 148
Kuo, M. T. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2095 · Cited by 163
“MRP1 was the first one in the family identified from a dox-orubicin-resistant human cell line that did not overexpress MDR1/Pgp1 (52).”
InfluentialModulation of oral bioavailability of anticancer drugs: from mouse to man
Schellens, J. H. M., Malingré, M. M., Kruijtzer, C. M. F., Bardelmeijer, H. A., van Tellingen, O., Schinkel, A. H., & Beijnen, J. H. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00153-6 · Cited by 154
Export pumps for glutathione S-conjugates
KEPPLER, D. O. R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00171-9 · Cited by 184
The GS-X Pump in Plant, Yeast, and Animal Cells: Structure, Function, and Gene Expression
Ishikawa, T., Li, Z.-S., Lu, Y., & Rea, P. A. (1997) · Bioscience Reports · doi:10.1023/a:1027385513483 · Cited by 162
Feller, N., Kuiper, C., Lankelma, J., Ruhdal, J., Scheper, R., Pinedo, H., & Broxterman, H. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.371 · Cited by 146
MDR1 gene expression in solid tumours
Goldstein, L. J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00100-1 · Cited by 146
Tammur, J., Prades, C., Reguigne-Arnould, I., Rzhetsky, A., Hutchinson, A. A., Adachi, M., Schuetz, J. D., Swoboda, K. J., Ptáček, L. J., Rosier, M., et al. (2001) · Gene · doi:10.1016/s0378-1119(01)00572-8 · Cited by 164
Liqi, L. A. I., & Tan, T. M. C. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610497 · Cited by 145
Stride, B. D., Grant, C. E., Loe, D. W., Hipfner, D. R., Cole, S. P. C., & Deeley, R. G. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.344 · Cited by 166
“MRP and Pgp are both members of the ATP-binding cassette transporter superfamily, but they share ,15% overall amino acid identity (1).”
BackgroundMethodSelf-citationWu, S., & Fu, L. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0775-3 · Cited by 150
“ABC transporter: ATP-binding cassette transporter; ABCB1: ATP binding cassette sub-family B member 1; ABCC1: ATP binding cassette sub-family C member 1; ABCG2: ATP binding cassette sub-family G member 2; ALK: ATP-competitive anaplastic lymphoma kinase; AML: Acute myelogenous leukemia; BCR-Abl: Breakpoint cluster regio…”
BackgroundInfluentialATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
Wang, J., Wu, Z., Yang, Y., Teng, Q., Li, Y., Lei, Z., Jani, K. A., Kaushal, N., & Chen, Z. (2021) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12434 · Cited by 143
Apoptosis in cancer—implications for therapy
Schulze‐Bergkamen, H., & Krammer, P. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.006 · Cited by 163
99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
Hendrikse, N. H., Franssen, E. J. F., van der Graaf, W., Meijer, C., Piers, D., Vaalburg, W., & de Vries, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.57 · Cited by 152
A systematic review of platinum and taxane resistance from bench to clinic: An inverse relationship
Stordal, B., Pavlakis, N., & Davey, R. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.07.013 · Cited by 144
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
Belinsky, M. G., & Kruh, G. D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690527 · Cited by 143
Sai, K., Kaniwa, N., Itoda, M., Saito, Y., Hasegawa, R., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Shirao, K., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00005 · Cited by 143
den Boer, M. L., Pieters, R., Kazemier, K. M., Rottier, M. M. A., Zwaan, C. M., Kaspers, G. J. L., Janka‐Schaub, G. E., Henze, G., Creutzig, U., Scheper, R. J., et al. (1998) · Blood · doi:10.1182/blood.v91.6.2092 · Cited by 143
Secondary and Tertiary Structure Changes of Reconstituted P-glycoprotein
Sonveaux, N., Shapiro, A. B., Goormaghtigh, E., Ling, V. W. T., & Ruysschaert, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24617 · Cited by 151
“…STE6, the mammalian cystic fibrosis transmembrane conductance regulator, the multidrug resistance-associated protein, and the bacterial periplasmic proteins involved in amino acids, sugar, and oligopeptide transport (Hyde et al., 1990; Cole et al., 1992; Higgins et al., 1992; Doige and Ames, 1993).”
BackgroundJanuchowski, R., Zawierucha, P., Andrzejewska, M., Ruciński, M., & Zabel, M. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.11.011 · Cited by 150
Yu, M., Ocaña, A., & Tannock, I. F. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9402-8 · Cited by 163
Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for Substrates
Ullrich, K. J. (1997) · The Journal of Membrane Biology · doi:10.1007/s002329900247 · Cited by 150
“Other transport systems, found in the proximal tubule, but functional role not assessed and not considered in this review are: the ATP driven multidrug transport system for cationic substrates mdr 1, cloned, twelve putative transmembrane segments, located at the luminal cell side [16, 18]; the ATP driven multidrug rel…”
BackgroundABCC2/Abcc2: a multispecific transporter with dominant excretory functions
Jemnitz, K., Herédi‐Szabó, K., Jánossy, J., Ioja, E., Vereczkey, L., & Krajcsi, P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491741 · Cited by 162
“The prior identification of ABCC1, then termed ABCC (Cole et al., 1992), has also aided in the identification of ABCC2.”
BackgroundRole of tumor vascular architecture in drug delivery
Narang, A. S., & Varia, S. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.04.002 · Cited by 162
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy
Theodossiou, T. A., Ali, M., Grigalavicius, M., Grallert, B., Dillard, P., Schink, K. O., Olsen, C. E., Wälchli, S., Inderberg, E. M., Kubin, A., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0108-8 · Cited by 154
Polymorphisms in the ABC drug transporter gene MDR1
Brinkmann, U., & Eichelbaum, M. F. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500001 · Cited by 164
Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer
Yuan, Y., Cai, T., Xia, X., Zhang, R., Chiba, P., & Cai, Y. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1178825 · Cited by 149
“MRP, discovered in the process of studying the small cell lung cancer drug-resistant line H69AR, is another member of the human ABC family of plasma membrane associated transporters causing MDR (Cole et al., 1992).”
BackgroundMorrow, C. S., Smitherman, P. K., Diah, S. K., Schneider, E., & Townsend, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20114 · Cited by 139
Versantvoort, C. H. M., Schuurhuis, G. J., Pinedo, H. M., Eekman, C., Kuiper, C. M., Lankelma, J., & Broxterman, H. J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.458 · Cited by 139
Modulation of P‐glycoprotein but not MRP1‐ or BCRP‐mediated drug resistance by LY335979
Shepard, R. L., Cao, J., Starling, J. J., & Dantzig, A. H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10792 · Cited by 138
ATPase Activity of Purified Multidrug Resistance-associated Protein
Chang, X.-B., Hou, Y.-X., & Riordan, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30962 · Cited by 138
Understanding and overcoming multidrug resistance in cancer
Ge, M., Chen, X.-Y., Huang, P., Fleishman, J. S., Yang, D., Wu, Z., Ke, Z., & Chen, Z. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01059-1 · Cited by 167
Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes
Hurwitz, S. J., Terashima, M., Mizunuma, N., & Slapak, C. A. (1997) · Blood · doi:10.1182/blood.v89.10.3745 · Cited by 137
Peng, K.-C., Cluzeaud, F., Bens, M., Duong Van Huyen, J.-P., Wioland, M. A., Lacave, R., & Vandewalle, A. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700605 · Cited by 137
Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters
Sorbo, G. D., Andrade, A. C., van Nistelrooy, J. G. M., van Kan, J. A. L., Balzi, E., & Waard, M. A. D. (1997) · Molecular and General Genetics MGG · doi:10.1007/s004380050434 · Cited by 141
“In addition to P-glycoproteins, another mammalian ABC transporter, the Multidrug Resistance-associated Protein (MRP), is also related to MDR (Cole et al. 1992).”
BackgroundHou, Y.-X., Cui, L., Riordan, J. R., & Chang, X.-B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001109200 · Cited by 137
The therapeutic potential of targeting ABC transporters to combat multi-drug resistance
Bugde, P., Biswas, R., Merien, F., Lu, J., Liu, D.-X., Chen, M., Zhou, S., & Li, Y. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1310841 · Cited by 135
“It was also found that knockdown of ABCC1 reduced themitotic index in neuroblastoma cell line xenograft [14].”
BackgroundInfluentialMultidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier
Régina, A., Demeule, M., Laplante, A., Jodoin, J., Dagenais, C., Berthelet, F., Moghrabi, A., & Béliveau, R. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013104423154 · Cited by 166
“Like P-gp, MRP1 is a member of the ABC superfamily and is expressed in many MDR cell lines which do not express P-gp [31–33].”
BackgroundDöring, B., & Petzinger, E. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.882353 · Cited by 135
Meng, X. L., Lou, Q., Yang, W., Wang, Y., Chen, R., Wang, L., Xu, T., & Zhang, L. (2021) · 癌症:英文版 · doi:10.1002/cac2.12194 · Cited by 148
“Since P-gp cannot explain all drug-resistant processes of cancer cells, MRP1, or ABCC1, was firstly identified in small cell lung cancer [82].”
BackgroundBagga, D., Ashley, J. M., Geffrey, S. P., Wang, H.-J., Barnard, R. J., Korenman, S. G., & Heber, D. (1995) · Cancer · doi:10.1002/1097-0142(19951215)76:12<2565::aid-cncr2820761224>3.0.co;2-b · Cited by 104
Ganesh, S., Iyer, A. K., Weiler, J., Morrissey, D. V., & Amiji, M. M. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.29 · Cited by 134
Nare, B., Luba, J. P., Hardy, L. W., & Beverley, S. M. (1997) · Parasitology · doi:10.1017/s0031182097001133 · Cited by 134
“PGPA, a member of the ABC family of membrane transporters belonging to the MRP subfamily of the P-glycoproteins (Cole et al. 1992; Ouellette, Legare & Papadopoulou, 1994), was shown to be responsible for arsenite resistance encoded by the H-region (Callahan & Beverley, 1991; Papadopoulou et al.…”
BackgroundBreast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators
Geisler, J. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00364-9 · Cited by 148
Glutathione and glutathione-dependent enzymes in cancer drug resistance
McLellan, L. I., & Wolf, C. R. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0083 · Cited by 146
van der Kolk, D. M., Vellenga, E., Scheffer, G. L., Müller, M. M., Bates, S. E., Scheper, R. J., & de Vries, E. G. E. (2002) · Blood · doi:10.1182/blood.v99.10.3763 · Cited by 141
Choi, J. H., Lou, W., & Vančura, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29915 · Cited by 167
Jansson, P. J., Yamagishi, T., Arvind, A., Seebacher, N. A., Gutierrez, E., Stacy, A. E., Maleki, S., Sharp, D. M., Sahni, S., & Richardson, D. R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.631283 · Cited by 137
ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP
Maltbaek, J. H., Cambier, S., Snyder, J. M., & Stetson, D. B. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.006 · Cited by 137
“MK-571 inhibits ABCC1, also known as multidrug resistance protein 1 (MRP1) (Cole et al., 1992; Leier et al., 1994).”
Hirrlinger, J., König, J., & Dringen, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01082.x · Cited by 131
“They are also involved in mediating resistance of tumour cells against chemotherapeutical drugs (Cole et al. 1992; König et al. 1999; Borst et al. 2000).”
BackgroundIto, K., Oleschuk, C. J., Westlake, C., Vasa, M. Z., Deeley, R. G., & Cole, S. P. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105160200 · Cited by 142
Self-citationP-glycoprotein Expression: Critical Determinant in the Response to Osteosarcoma Chemotherapy
Chan, H. S. L., Haddad, G., DeBoer, G., Ling, V. W. T., & Grogan, T. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.22.1706 · Cited by 132
Molecular imaging of gene expression and protein function in vivo with PET and SPECT
Sharma, V., Luker, G. D., & Piwnica-Worms, D. R. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10182 · Cited by 129
“Several of the first characterized mechanisms of MDR include transporter-mediated resistance conferred by increased expression of the Mr 170,000 transmembrane glycoprotein, P-glycoprotein (Pgp), the product of the MDR1 gene (104–108), and a related Mr 190,000 membrane glycoprotein, the MDR-associated protein (MRP1) (1…”
BackgroundInfluentialKojima, H., Endo, K., Moriyama, H., Tanaka, Y., Alnemri, E. S., Slapak, C. A., Teicher, B., Kufe, D., & Datta, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16647 · Cited by 131
Effect of Flavonoids on MRP1-Mediated Transport in Panc-1 Cells
Nguyen, H. T. T., Zhang, S., & Morris, M. E. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10283 · Cited by 142
Functional expression of P-glycoproteins in secretory vesicles.
Ruetz, S., & Gros, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32712-6 · Cited by 142
Yamasaki, M., Makino, T., Masuzawa, T., Kurokawa, Y., Miyata, H., Takiguchi, S., Nakajima, K., Fujiwara, Y., Matsuura, N., Mori, M., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606071 · Cited by 130
“The first ABC transporter identified in this context was P-glycoprotein (PgP, MDR1, ABCB1) (Kartner et al, 1983), and in the absence of overexpressed MDR1, the protein MRP1, ABCC1 was discovered because of the MDR phenotype (Cole et al, 1992).”
BackgroundThe Role of Half-Transporters in Multidrug Resistance
Bates, S. E., Robey, R. W., Miyake, K., Rao, K. V., Ross, D. D., & Litman, T. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012879205914 · Cited by 130
Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy
Huang, Y. S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9050-6 · Cited by 144
“ABCC1 (multidrug resistance protein 1, MRP1) was discovered in a small-cell lung cancer cell line showing multidrug resistance without overexpressing ABCB1 [51].”
BackgroundThe barrier and interface mechanisms of the brain barrier, and brain drug delivery
Zhang, S., Gan, L., Cao, F., Wang, H., Gong, P., Ma, C., Ren, L., Lin, Y., & Lin, X. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.09.017 · Cited by 129
Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
Sissung, T. M., Baum, C. E., Kirkland, C. T., Gao, R., Gardner, E. R., & Figg, W. D. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9220-6 · Cited by 146
“ABCC1 is known to be involved in anthracycline transport [52], but ABCC2 effluxes a wider range of drugs such as cyclosporin A, cisplatin, vinblastine, and camptothecan derivatives [19, 53].”
BackgroundWang, H., Lee, D.-K., Chen, K., Chen, J.-Y., Zhang, K., Silva, A., Ho, C., & Ho, D. (2015) · ACS Nano · doi:10.1021/acsnano.5b00638 · Cited by 134
“characterized by system robustness, redundant pathways, crosstalk, anti-target, counter target activity, as well as compensatory and neutralizing actions.(11-16) These complex”
Twentyman, P. R., Rhodes, T., & Rayner, S. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90187-2 · Cited by 129
He, L., Yang, C. P., & Horwitz, S. B. (2001) · PubMed · Cited by 141
Katzmann, D. J., Hallstrom, T. C., Mahé, Y., & Moye-Rowley, W. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23049 · Cited by 128
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128
ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?
Steinbach, D., & Legrand, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404692 · Cited by 142
The ABC transporter gene family of Daphnia pulex
Sturm, A., Cunningham, P., & Dean, M. C. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-170 · Cited by 143
“Subsequent studies have identified further ABC proteins that are drug efflux pumps and can cause MDR in cancers, including the multidrug resistance associated protein (hABCC1/MRP1) [16] and the breast cancer related protein (hABCG2/ BCRP) [17].”
BackgroundRoepe, P. D., Li, W., Cruz, J., & Carlson, D. (1993) · Biochemistry · doi:10.1021/bi00092a014 · Cited by 127
Characterization of a stem cell population in lung cancer A549 cells
Sung, J.-M., Cho, H., Yi, H., Lee, C.-H., Kim, H., Kim, D., El‐Aty, A. M. A., Kim, J.-S., Landowski, C. P., Hediger, M. A., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.038 · Cited by 135
Toyoda, Y., Hagiya, Y., Adachi, T., Hoshijima, K., Kuo, M. T., & Ishikawa, T. (2008) · Xenobiotica · doi:10.1080/00498250701883514 · Cited by 147
“In 1992, Cole et al. used a differential screening approach to clone a cDNA encoding a deduced protein of 190 kDa, which they named MRP, that was over-expressed in a doxorubicin-resistant cell line (Cole et al. 1992).”
BackgroundMethodTrompier, D., Chang, X.-B., Barattin, R., d’Hardemare, A. D. M., Di Pietro, A., & Baubichon-Cortay, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0143 · Cited by 127
“Two of the best characterized examples of these transporters are the P-glycoprotein (P-gp) and the multidrug resistance protein 1 (MRP1), encoded by the human ABCB1 and ABCC1 genes, respectively (1, 2).”
BackgroundRaghunand, N., Martínez–Zaguilán, R., Wright, S. H., & Gillies, R. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00021-0 · Cited by 139
“In addition, an MRP has been cloned from a multidrugresistant, doxorubicin-selected cell line that did not overexpress P-gp [5].”
Cui, Z., Hirata, D., Tsuchiya, E., Osada, H., & Miyakawa, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14712 · Cited by 126
Considerations in the design and development of transport inhibitors as adjuncts to drug therapy
Dantzig, A. H., de Alwis, D. P., & Burgess, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00175-8 · Cited by 152
Guerci‐Bresler, A., Merlin, J. L., Missoum, N., Feldmann, L., Marchal, S., Witz, F., Rose, C., & Guerci, O. (1995) · Blood · doi:10.1182/blood.v85.8.2147.bloodjournal8582147 · Cited by 127
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.